Neuroprotection by histone deacetylase-related protein
Abstract
The expression of histone deacetylase-related protein (HDRP) is reduced in neurons undergoing apoptosis. Forced reduction of HDRP expression in healthy neurons by treatment with antisense oligonucleotides also induces cell death. Likewise, neurons cultured from mice lacking HDRP are more vulnerable to cell death. Adenovirally mediated expression of HDRP prevents neuronal death, showing that HDRP is a neuroprotective protein. Neuroprotection by forced expression of HDRP is not accompanied by activation of the phosphatidylinositol 3-kinase-Akt or Raf-MEK-ERK signaling pathway, and treatment with pharmacological inhibitors of these pathways fails to inhibit the neuroprotection by HDRP. Stimulation of c-Jun phosphorylation and expression, an essential feature of neuronal death, is prevented by HDRP. We found that HDRP associates with c-Jun N-terminal kinase (JNK) and inhibits its activity, thus explaining the inhibition of c-Jun phosphorylation by HDRP. HDRP also interacts with histone deacetylase 1 (HDAC1) and recruits it to the c-Jun gene promoter, resulting in an inhibition of histone H3 acetylation at the c-Jun promoter. Although HDRP lacks intrinsic deacetylase activity, treatment with pharmacological inhibitors of histone deacetylases induces apoptosis even in the presence of ectopically expressed HDRP, underscoring the importance of c-Jun promoter deacetylation by HDRP-HDAC1 in HDRP-mediated neuroprotection. Our results suggest that neuroprotection by HDRP is mediated by the inhibition of c-Jun through its interaction with JNK and HDAC1.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HDAC inhibitors demonstrate anti-inflammatory and neuroprotective effects in neurodegenerative models by dampening inflammatory signaling and supporting synaptic and cognitive function.
“HDAC inhibitors also demonstrate anti-inflammatory and neuroprotective effects in neurodegenerative models by dampening inflammatory signaling and supporting synaptic and cognitive function (Morrison et al., 2006; Zhou et al., 2018; Kumar et al., 2022).”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Morrison et al., 2006
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114 · see citing works
Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., RAKIC, P. T., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,230 · see citing works
Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,193 · see citing works
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,051 · see citing works
Self-citationD'Mello, S. R., Galli, C., Ciotti, T., & Calissano, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10989 · Cited by 892 · see citing works
Self-citationHockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi‐Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 847 · see citing works
A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death
Ham, J., Babij, C., Whitfield, J. R., Pfarr, C. M., Lallemand, D., Yaniv, M., & Rubin, L. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90331-3 · Cited by 796 · see citing works
Ferrante, R. J., Kubilus, J. K., Lee, J.-H., Ryu, H., Beesen, A. A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi‐Carter, R., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 694 · see citing works
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664 · see citing works
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 520 · see citing works
Self-citationLu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518 · see citing works
Self-citationHistone Deacetylase Inhibitors
Marks, P. A., Richon, V. M., Miller, T., & Kelly, W. K. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)91004-4 · Cited by 424 · see citing works
Watson, A., Eilers, A., Lallemand, D., Kyriakis, J. M., Rubin, L. L., & Ham, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00751.1998 · Cited by 360 · see citing works
Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration
Rouaux, C., Jokic, N., Mbebi, C., Boutillier, S., Loeffler, J., & Boutillier, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg615 · Cited by 302 · see citing works
Role of extracellular signal regulated kinases 1 and 2 in neuronal survival
Hetman, M., & Góźdź, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04133.x · Cited by 274 · see citing works
Regulating histone acetyltransferases and deacetylases
Legube, G., & Trouche, D. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor941 · Cited by 261 · see citing works
Ryu, H., Lee, J.-H., Olofsson, B. A., Mwidau, A., Deodoglu, A., Escudero, M., Flemington, E. K., Azizkhan‐Clifford, J., Ferrante, R. J., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737363100 · Cited by 261 · see citing works
c-Jun and the transcriptional control of neuronal apoptosis
Ham, J., Eilers, A., Whitfield, J. R., Neame, S. J., & Shah, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00372-5 · Cited by 242 · see citing works
Johnson, D., Horsley, S. W., Moloney, D. M., Oldridge, M., Twigg, S. R. F., Walsh, S., Barrow, M., Njølstad, P. R., Kunz, J., Ashworth, G. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302122 · Cited by 230 · see citing works
MEF‐2 function is modified by a novel co‐repressor, MITR
Sparrow, D. B., Miska, E. A., Langley, E., Reynaud‐Deonauth, S., Kotecha, S., Towers, N., Spohr, G., Kouzarides, T., & Mohun, T. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5085 · Cited by 196 · see citing works
Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death
Bolger, T. A., & Yao, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-05.2005 · Cited by 190 · see citing works
Coffey, E. T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen, T., & Courtney, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04335.2002 · Cited by 184 · see citing works
Lukiw, W. J., & Bazan, N. G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5 · Cited by 183 · see citing works
Self-citationLangley, B. C., Gensert, J. M., Beal, M. F., & Ratan, R. R. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053005091 · Cited by 169 · see citing works
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
Petrie, K. R., Guidez, F., Howell, L., Healy, L. E., Waxman, S., Greaves, M. F., & Zelent, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212935200 · Cited by 146 · see citing works
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 145 · see citing works
Sée, V., Boutillier, A., Bito, H., & Loeffler, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0106com · Cited by 138 · see citing works
Targeting JNK3 for the treatment of neurodegenerative disorders
Resnick, L., & Fennell, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03251-9 · Cited by 128 · see citing works
Linseman, D. A., Bartley, C. M., Le, S. S., Laessig, T. A., Bouchard, R. J., Meintzer, M. K., Li, M., & Heidenreich, K. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307245200 · Cited by 124 · see citing works
Zhou, X., Richon, V. M., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1056 · Cited by 120 · see citing works
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131198498 · Cited by 118 · see citing works
Self-citationNeuronal apoptosis induced by histone deacetylase inhibitors
Salminen, A., Tapiola, T., Korhonen, P., & Suuronen, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00210-1 · Cited by 109 · see citing works
Hack, N., Hidaka, H., Wakefield, M. J., & Balázs, R. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90108-r · Cited by 103 · see citing works
Targeting the JNK Signaling Pathway for Stroke and Parkinsons Diseases Therapy
Kuan, C.-Y., & Burke, R. E. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053005145 · Cited by 100 · see citing works
Phenotypic findings due to trisomy 7p15.3-pter including theTWIST locus
Stankiewicz, P., Thiele, H., Baldermann, C., Kr�ger, A., Giannakudis, I., D�rr, S., Werner, N., Kunz, J., Rappold, G. A., & Hansmann, I. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1512 · Cited by 97 · see citing works
Koulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00134.x · Cited by 97 · see citing works
Self-citationBoutillier, A., Trinh, E., & Loeffler, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01581.x · Cited by 94 · see citing works
Diversity in the Sir2 family of protein deacetylases
Buck, S. W., Gallo, C. M., & Smith, J. S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0903424 · Cited by 94 · see citing works
Chin, P. C., Liu, L., Morrison, B. E., Siddiq, A., Ratan, R. R., Bottiglieri, T., & D’Mello, S. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02530.x · Cited by 93 · see citing works
Self-citationKoulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00303.x · Cited by 77 · see citing works
Self-citationTargeting the JNK Pathway for Therapeutic Benefit in CNS Disease
Bozyczko‐Coyne, D., Saporito, M. S., & Hudkins, R. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339472 · Cited by 68 · see citing works
Graczyk, P. P., Khan, A., Bhatia, G. S., Palmer, V. H., Medland, D., Numata, H., Oinuma, H., Catchick, J., Dunne, A., Ellis, M. V., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.076 · Cited by 56 · see citing works
Keramaris, E., Vanderluit, J. L., Bahadori, M. H., Mousavi, K., Davis, R. J., Flavell, R. A., Slack, R. S., & Park, D. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410127200 · Cited by 42 · see citing works
Yalcin, A., Koulich, E., Mohamed, S. A., Liu, L., & D’Mello, S. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01540.x · Cited by 39 · see citing works
Self-citationLoss of heterozygosity at 7p in Wilms’ tumour development
Powlesland, R. M., CHARLES, A. K., Malik, K. T. A., Reynolds, P. A., Pires, S., Boavida, M. G., & Brown, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0922 · Cited by 38 · see citing works
Schmidt, H., Taubert, H. W., Würl, P., Kappler, M., Lange, H., Bartel, F., Bache, M., Holzhausen, H. ‐., & Hinze, R. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10036 · Cited by 32 · see citing works
Boutillier, A., Trinh, E., & Loeffler, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04679.x · Cited by 28 · see citing works
Lewanda, A. F., Green, E. D., Weissenbach, J., Jerald, H., Taylor, E. W., Summar, M. L., Phillips, J. A., COHEN, M. P., Feingold, M., & Mouradian, W. E. (1994) · PubMed Central · Cited by 22 · see citing works
Borrás, E., Zaragozá, R., Morante, M., Garcı́a, C., Gimeno, A., López‐Rodas, G., Barber, T., Miralles, V. J., Vinã, J. R., & Torres, L. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03511.x · Cited by 19 · see citing works
Flagged first, then by citations
2 of the 51 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 715 · see citing works
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Nand, S., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Singh, B. K., Singh, S. P., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 480 · see citing works
Epigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373 · see citing works
Targeting the correct HDAC(s) to treat cognitive disorders
Fischer, A., Sananbenesi, F., Mungenast, A. E., & Tsai, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.003 · Cited by 355 · see citing works
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J.-S., Lee, B.-H., Moy, L. Y., Giusti, P., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.015 · Cited by 286 · see citing works
Manda, K., Ueno, M., & Anzai, K. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00432.x · Cited by 222 · see citing works
HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage
Kim, J. Y., Shen, S., Dietz, K., He, Y., Howell, O. W., Reynolds, R., & Casaccia, P. (2009) · Nature Neuroscience · doi:10.1038/nn.2471 · Cited by 215 · see citing works
Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210 · see citing works
Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
Brunmeir, R., Lagger, S., & Seiser, C. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082649rb · Cited by 196 · see citing works
Kozikowski, A. P., Tapadar, S., Luchini, D. N., Kim, K. H., & Billadeau, D. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002894 · Cited by 190 · see citing works
Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
Lee, S. J., Krauthauser, C. M., Maduskuie, V., Fawcett, P. T., Olson, J. M., & Langhans, S. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-144 · Cited by 168 · see citing works
Histone deacetylases 1 and 2 are expressed at distinct stages of neuro‐glial development
MacDonald, J. L., & Roskams, A. J. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21626 · Cited by 166 · see citing works
Necdin Regulates p53 Acetylation via Sirtuin1 to Modulate DNA Damage Response in Cortical Neurons
Hasegawa, K., & Yoshikawa, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3052-08.2008 · Cited by 162 · see citing works
Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β
Bardai, F. H., & D’Mello, S. R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5704-10.2011 · Cited by 158 · see citing works
Self-citationHistone deacetylases (HDACs) and brain function
Volmar, C.-H., & Wahlestedt, C. (2015) · Neuroepigenetics · doi:10.1016/j.nepig.2014.10.002 · Cited by 151 · see citing works
Confirmed rare copy number variants implicate novel genes in schizophrenia
Tam, G. W. C., van de Lagemaat, L. N., Redon, R., Strathdee, K. E., Croning, M. D. R., Malloy, M. P., Muir, W. J., Pickard, B. S., Deary, I. J., Blackwood, D. H. R., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380445 · Cited by 139 · see citing works
Histone Deacetylase-1 (HDAC1) Is a Molecular Switch between Neuronal Survival and Death
Bardai, F. H., Price, V. J., Zaayman, M., Wang, L., & D’Mello, S. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394544 · Cited by 134 · see citing works
Self-citationEpigenetic regulation of nervous system development by DNA methylation and histone deacetylation
MacDonald, J. L., & Roskams, A. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.002 · Cited by 136 · see citing works
HDAC4 inhibits cell‐cycle progression and protects neurons from cell death
Majdzadeh, N., Wang, L., Morrison, B. E., Bassel‐Duby, R., Olson, E. N., & D’Mello, S. R. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20637 · Cited by 135 · see citing works
Self-citationChen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 133 · see citing works
HDAC inhibitors and neurodegeneration: At the edge between protection and damage
Dietz, K. C., & Casaccia, P. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.011 · Cited by 126 · see citing works
Kozikowski, A. P., Chen, Y., Gaysin, A. M., Chen, B., D’Annibale, M. A., Suto, C. M., & Langley, B. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070178x · Cited by 122 · see citing works
Caslini, C., Hong, S., Ban, Y. J., Chen, X. S., & Ince, T. A. (2019) · Oncogene · doi:10.1038/s41388-019-0897-0 · Cited by 121 · see citing works
The promise and perils of HDAC inhibitors in neurodegeneration
Didonna, A., & Opal, P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.147 · Cited by 120 · see citing works
Manda, K., Ueno, M., & Anzai, K. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00611.x · Cited by 101 · see citing works
FoxG1 Promotes the Survival of Postmitotic Neurons
Dastidar, S. G., Landrieu, P. M. Z., & D’Mello, S. R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2897-10.2011 · Cited by 99 · see citing works
Self-citationElsner, V. R., Lovatel, G. A., Bertoldi, K., Vanzella, C., Santos, F., Spindler, C. D. F., de Almeida, E. F., Nardin, P., & Siqueira, I. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.066 · Cited by 98 · see citing works
Manda, K., Ueno, M., & Anzai, K. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00632.x · Cited by 97 · see citing works
Shaping brain connections through spontaneous neural activity
Yamamoto, N., & López‐Bendito, G. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08101.x · Cited by 86 · see citing works
Sugo, N., Oshiro, H., Takemura, M., Kobayashi, T., Kohno, Y., Uesaka, N., Song, W., & Yamamoto, N. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07218.x · Cited by 85 · see citing works
Histone deacetylases: Focus on the nervous system
Morrison, B. E., Majdzadeh, N., & D’Mello, S. R. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7035-9 · Cited by 81 · see citing works
Self-citationMa, C., & D’Mello, S. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146860 · Cited by 80 · see citing works
Self-citationEgr-1 TransactivatesBimGene Expression to Promote Neuronal Apoptosis
Xie, B., Wang, C., Zheng, Z., Song, B., Ma, C., Thiel, G., & Li, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5504-10.2011 · Cited by 77 · see citing works
Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117278 · Cited by 79 · see citing works
Complex neuroprotective and neurotoxic effects of histone deacetylases
Thomas, E. A., & D’Mello, S. R. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14309 · Cited by 75 · see citing works
Self-citationAminoglycoside‐induced histone deacetylation and hair cell death in the mouse cochlea
Chen, F., Schacht, J., & Sha, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05871.x · Cited by 75 · see citing works
Morris, M. J., & Monteggia, L. M. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.005 · Cited by 75 · see citing works
Regional and subcellular distribution of HDAC4 in mouse brain
Darcy, M. J., Calvin, K., Cavnar, K., & Ouimet, C. C. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22241 · Cited by 69 · see citing works
Narne, P., Pandey, V., & Phanithi, P. B. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1141-6 · Cited by 70 · see citing works
Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death
Jin, H., Kanthasamy, A., Harischandra, D. S., Kondru, N. C., Ghosh, A., Panicker, N., Anantharam, V., Rana, A., & Kanthasamy, A. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576702 · Cited by 67 · see citing works
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Yang, C., Croteau, S., & Hardy, P. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00626-9 · Cited by 63 · see citing works
Ganai, S. A., Banday, S., Farooq, Z., & Altaf, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.001 · Cited by 60 · see citing works
Thomas, E. A. (2014) · Pharmaceuticals · doi:10.3390/ph7060634 · Cited by 51 · see citing works
Oh, S., Lee, J., Kwon, M., Weir, B. S., Ha, K., & Park, T. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s9-s5 · Cited by 50 · see citing works
Edamakanti, C. R., Albanito, L., Marco, P. D., Aiello, D., Maggiolini, M., Napoli, A., & Musti, A. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.381 · Cited by 50 · see citing works
Pirooznia, S. K., & Elefant, F. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00030 · Cited by 51 · see citing works
Lang, B., Alrahbeni, T. M. A., Clair, D. S., Blackwood, D., McCaig, C., & Shen, S. (2012) · Europe PMC (PubMed Central) · Cited by 48 · see citing works
Harrison, B. C., Huynh, K. Q., Lundgaard, G. L., Helmke, S. M., Perryman, M. B., & McKinsey, T. A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.057 · Cited by 49 · see citing works
KSRP: A checkpoint for inflammatory cytokine production in astrocytes
Li, X., Lin, W., Chen, C., Si, Y., Zhang, X., Lu, L., Suswam, E. A., Zheng, L., & King, P. H. (2012) · Glia · doi:10.1002/glia.22396 · Cited by 47 · see citing works
Self-citationHistone deacetylase‐related protein inhibits AES‐mediated neuronal cell death by direct interaction
Zhang, X., Chen, H., Jaramillo, E., Wang, L., & D’Mello, S. R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21680 · Cited by 44 · see citing works
Self-citationInter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling
Balmik, A. A., & Chinnathambi, S. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151202 · Cited by 44 · see citing works
Class IIA HDACs in the regulation of neurodegeneration
Majdzadeh, N. (2007) · Frontiers in bioscience · doi:10.2741/2745 · Cited by 44 · see citing works
Self-citationHou, X., Weng, Y., Wang, T., Ouyang, B., Li, Y., Song, Z., Pan, Y., Zhang, Z., Zou, W., Huang, C., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.026 · Cited by 44 · see citing works
Tapadar, S., He, R. L., Luchini, D. N., Billadeau, D. D., & Kozikowski, A. P. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.058 · Cited by 42 · see citing works
Targeting histone deacetylases for heart failure
Bush, E. W., & McKinsey, T. A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902939161 · Cited by 42 · see citing works
Histone deacetylases 1 and 2 are required for brain development
Jaworska, J., Ziemka‐Nałęcz, M., & Zalewska, T. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150071tz · Cited by 41 · see citing works
Wang, L., Ankati, H., Akubathini, S. K., Balderamos, M., Storey, C. A., Patel, A. V., Price, V. J., Kretzschmar, D., Biehl, E. R., & D’Mello, S. R. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22352 · Cited by 40 · see citing works
Self-citationClass II and IV HDACs function as inhibitors of osteoclast differentiation
Blixt, N. C., Faulkner, B., Astleford, K., Lelich, R., Schering, J., Spencer, E., Gopalakrishnan, R., Jensen, E. D., & Mansky, K. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185441 · Cited by 39 · see citing works
Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17
Mojsa, B., Mora, S., Bossowski, J. P., Lassot, I., & Desagher, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.141 · Cited by 38 · see citing works
Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
Chung, J., Zhang, X., Allen, M., Wang, X., Ma, Y., Beecham, G. W., Montine, T. J., Younkin, S. G., Dickson, D. W., Golde, T. E., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0349-z · Cited by 37 · see citing works
Self-citationOpportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
Klingl, Y. E., Pakravan, D., & Bosch, L. V. D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15217 · Cited by 32 · see citing works
Dastidar, S. G., Narayanan, S., Stifani, S., & D’Mello, S. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328336 · Cited by 33 · see citing works
Self-citationDemyanenko, S. V., Neginskaya, M. A., & Berezhnaya, E. V. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0595-6 · Cited by 33 · see citing works
Gatta, V., Drago, D., Fincati, K., Valenti, M. T., Carbonare, L. D., Sensi, S. L., & Zatta, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015965 · Cited by 30 · see citing works
HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis
Chen, J., Wang, H., Hsu, C.-Y., Su, Y.-T., Chen, J., Liang, C., Hsieh, P. C. H., Wu, C., & Kwan, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-95837-3 · Cited by 29 · see citing works
Balderamos, M., Ankati, H., Akubathini, S. K., Patel, A. V., Kamila, S., Mukherjee, C., Wang, L., Biehl, E. R., & D’Mello, S. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0805-rm-153 · Cited by 29 · see citing works
Self-citationHistone deacetylase in neuropathology
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.004 · Cited by 28 · see citing works
Histone Deacetylase 9 Activates γ-Globin Gene Expression in Primary Erythroid Cells
Muralidhar, S. A., Ramakrishnan, V., Kalra, I. S., Li, W., & Pace, B. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115725 · Cited by 28 · see citing works
Price, V. J., Wang, L., & D’Mello, S. R. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23170 · Cited by 28 · see citing works
Self-citationRegulation of Central Nervous System Development by Class I Histone Deacetylases
D’Mello, S. R. (2019) · Developmental Neuroscience · doi:10.1159/000505535 · Cited by 28 · see citing works
Self-citationHistone deacetylase inhibition reduces cardiac connexin43 expression and gap junction communication
Xu, Q., Lin, X., Andrews, L. E., Patel, D., Lampe, P. D., & Veenstra, R. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00044 · Cited by 27 · see citing works
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
Klemann, C. J. H. M., Martens, G. J. M., Poelmans, G., & Visser, J. E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9103-8 · Cited by 26 · see citing works
The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression
Titus, A. S. C. L. S., Sharma, D., Kim, M. S., & D’Mello, S. R. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0546-0 · Cited by 26 · see citing works
Self-citationHistone deacetylase-3: Friend and foe of the brain
D’Mello, S. R. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220928278 · Cited by 26 · see citing works
Self-citationPolydactyly in Mice Lacking HDAC9/HDRP
Morrison, B. E., & D’Mello, S. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0802-rm-48 · Cited by 24 · see citing works
Self-citationWen, L., Wang, J., WANG, Y., & Chen, F. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2236 · Cited by 22 · see citing works
Salian‐Mehta, S., Xu, M., McKinsey, T. A., Tobet, S. A., & Wierman, M. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640482 · Cited by 19 · see citing works
Chromatin Acetylation Status in the Manifestation of Neurodegenerative Diseases
Boutillier, A., Rouaux, C., Panteleeva, I., & Loeffler, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_12 · Cited by 19 · see citing works
Oliveira, G. S. D., Iraci, L., Pinheiro, G. S., Casal, M. Z., Haas, A. N., Pochmann, D., Martinez, F. G., Elsner, V. R., & Dani, C. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113135 · Cited by 18 · see citing works
Choi, H.-J., Kwon, S., & Kim, D. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.006 · Cited by 18 · see citing works
Chen, J., Wang, H., Su, Y.-T., Hsu, C.-Y., Chen, J., Liang, C., Wu, C., & Kwan, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910654 · Cited by 17 · see citing works
Implications of epigenetic modulation for novel treatment approaches in patients with schizophrenia.
Cha, D., Kudlow, P., Baskaran, A., Mansur, R., & McIntyre, R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.038 · Cited by 20 · see citing works
Musacchio, T., Yin, J., Kremer, F., Koprich, J. B., Brotchie, J. M., Volkmann, J., & Ip, C. W. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113968 · Cited by 14 · see citing works
Qu, Z., & D’Mello, S. R. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218761149 · Cited by 14 · see citing works
Self-citationIntracellular translocation of histone deacetylase 5 regulates neuronal cell apoptosis
Wei, J., Lu, Q., Li, W., & He, W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.043 · Cited by 13 · see citing works
HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
Squarzoni, A., Scuteri, A., & Cavaletti, G. (2022) · Cancers · doi:10.3390/cancers14215251 · Cited by 11 · see citing works
Human neuronal cells: epigenetic aspects
Kukucka, J., Wyllie, T., Read, J. L., Mahoney, L., & Suphioglu, C. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2012-0053 · Cited by 10 · see citing works
With Gottlieb beyond Gottlieb: The Role of Epigenetics in Psychobiological Development
Lux, V. (2013) · International Journal of Developmental Science · doi:10.3233/dev-1300073 · Cited by 10 · see citing works
Epigenetic Study of Parkinson's Disease in Experimental Animal Model
Salama, A. F., Ibrahim, W., Tousson, E., Sakr, S. A., Masoud, A., Akela, M. A., & El-Rahman, M. A. A. (2015) · Clinical and experimental neurology · doi:10.12691/ijcen-3-1-3 · Cited by 9 · see citing works
Histone-Mediated Transgenerational Epigenetics
Li, J., Ding, Y., & Zheng, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405944-3.00009-x · Cited by 9 · see citing works
Cahill, C. M., Sarang, S. S., Bakshi, R., Xia, N., Lahiri, D. K., & Rogers, J. T. (2024) · Biomolecules · doi:10.3390/biom14060647 · Cited by 8 · see citing works
Lv, L.-Z., Wang, Z.-D., Ren, J.-J., Li, L.-H., Liu, X.-B., Li, J.-L., Zhu, H., Jiang, B., Han, Y.-P., Zhou, X.-M., et al. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1722453 · Cited by 7 · see citing works
Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s
Gautam, N., WANG, S. S., Üren, A., Chapagain, P. P., Adhikari, N. P., & Tiwari, P. B. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00858 · Cited by 4 · see citing works
Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1
Pfister, J. A., Ma, C., & D’Mello, S. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215208 · Cited by 4 · see citing works
Self-citationYan, Y., & Jiao, R. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch6 · Cited by 1 · see citing works
Characterization of HDAC4's role in brain
Darcy, M. (2010)
Lee, Y. A., Na, W., Lee, K., Lee, H. S., & Ju, B. (2015) · Genes & Genomics · doi:10.1007/s13258-015-0282-5
Bagchi, R. A., Bagchi, A. K., Salunke, A., Hens, D. K., & Parikh, P. (2019) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v2i3.30
Zhao, Z., Diao, X., Cao, Q., & Lu, X. (2023) · Annals of Medical and Clinical Oncology · doi:10.29011/2833-3497.000144
Frank, L. E., Flack, N., Faulk, C. D., Block, A. J., Bartz, J. C., & Larsen, P. A. (2026) · Prion · doi:10.1080/19336896.2026.2710965
- Authors
- Morrison, B. E., Majdzadeh, N., Zhang, X., Lyles, A., Bassel-Duby, R., Olson, E. N., & D'Mello, S. R.
- Affiliations
- The University of Texas at Dallas (US)
- Department of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390
- The University of Texas Southwestern Medical Center (US)
- Department of Molecular and Cell Biology, University of Texas at Dallas, 2601 N. Floyd Rd., Richardson, Texas 75083
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-05-01
- Volume
- 26
- Issue
- 9
- Pages
- 3550-3564
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2024126284
- Cited by
- 100
- References
- 51
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 8 · 2014: 6 · 2013: 7 · 2012: 7
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS047201, R01NS040408, NS40408, R01NS047201)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- neuroprotection, neuronal apoptosis, c-Jun phosphorylation, c-Jun N-terminal kinase, HDAC1, histone H3 acetylation, c-jun promoter, phosphatidylinositol 3-kinase/Akt signaling, MAPK/ERK pathway, antisense oligonucleotides, adenoviral gene expression, histone deacetylase inhibitors
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Nucleus, Enzyme Inhibitors, Histone Deacetylases, Neurons, Phosphorylation, RNA, Messenger, Transcription, Genetic, Proto-Oncogene Proteins c-jun, Apoptosis, Phosphatidylinositol 3-Kinases, JNK Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review